Skip to content

Sleep Disorder, Shift Work (Shift Work Disorder, SWD)

BASICS

  • Definition:
  • Circadian rhythm sleep-wake disorder, characterized by insomnia and/or excessive sleepiness due to misalignment between internal circadian rhythms and required sleep-wake schedules from nontraditional work shifts (night, evening, early morning, rotating, irregular).
  • Systems affected: nervous, cardiovascular, metabolic

EPIDEMIOLOGY

  • Prevalence:
  • 20% of U.S. employed adults are shift workers (esp. healthcare, transportation, food services, protective services)
  • 1 in 3 shift workers experience insomnia or sleep disturbance; ~90% report daytime sleepiness/fatigue
  • Estimated SWD prevalence: 2–5% in the general U.S. population
  • Risk increases with age (>50 years)

ETIOLOGY & PATHOPHYSIOLOGY

  • Pathophysiology:
  • Circadian misalignment between endogenous rhythms and nontraditional sleep-wake schedules leads to sleep onset/maintenance insomnia and/or excessive sleepiness during required awake hours
  • Genetics:
  • Morning/evening preference partially linked to polymorphisms of the PER3 clock gene

RISK FACTORS

  • Age >50 years
  • Strong social/domestic demands
  • Prolonged/irregular shift schedules

PREVENTION

  • Reduce or avoid shift work if possible
  • Rotate shifts forward (morning β†’ afternoon β†’ night)
  • Bright light exposure during shifts
  • Consistent sleep schedule, strategic naps before or during shift
  • Practice sleep hygiene

COMMONLY ASSOCIATED CONDITIONS

  • Impaired recall, decreased processing speed, attention deficits
  • Increased risk: vehicular/work accidents, GI disorders, CVD, diabetes, possible cancers
  • Higher rates of mood disorders and substance use

DIAGNOSIS

DSM-5 Criteria (Circadian Rhythm Sleep-Wake Disorder)

  • Persistent/recurrent sleep disruption due to circadian misalignment (physical/social/professional)
  • Leads to excessive sleepiness and/or insomnia
  • Causes significant distress/impairment in functioning

Additional SWD Criteria

  • Insomnia during sleep period and/or excessive sleepiness during awake period tied to shift work
  • Classified as: episodic (1–3 mo), persistent (>3 mo), or recurrent (β‰₯2 episodes/year)

HISTORY

  • Detailed sleep/work history, degree of sleepiness, performance/safety risk
  • Evaluate for coexisting sleep disorders (OSA, RLS, narcolepsy)

PHYSICAL EXAM

  • Assess for mood disorders, obesity/large neck (OSA risk), CVD, diabetes, GI disease

DIFFERENTIAL DIAGNOSIS

  • Primary insomnia, sleep-related breathing disorders, central hypersomnolence, parasomnias, movement disorders
  • Other circadian rhythm disorders (delayed sleep phase, irregular sleep-wake)

DIAGNOSTIC TESTS

  • Diagnosis is clinical; no routine labs
  • Consider polysomnography or multiple sleep latency test if other sleep disorder suspected
  • 2-week sleep diary, Insomnia Severity Index (ISI), Epworth Sleepiness Scale (ESS) can aid in assessment

TREATMENT

GENERAL MEASURES

  • Sleep hygiene:
  • Minimize light before/during sleep (dark room, blackout shades, sunglasses after shift)
  • Quiet, cool environment, white noise, ear plugs
  • Avoid stimulants during latter half of shift
  • Scheduled/protected sleep:
  • Anchor sleep (consistent sleep blocks overlapping work/nonwork days)
  • Strategic naps (<1 hour) before/during shift (beware post-nap sleep inertia)
  • Lifestyle:
  • Manage stress/depression, healthy diet, regular exercise (avoid within 2–4h of bedtime), limit substances
  • Social support for sleep protection
  • Work modifications:
  • <4 consecutive shifts, shift duration <12h, >11h between shifts, avoid heavy work during circadian nadir (4–7am)

LIGHT EXPOSURE

  • Bright light therapy (>2,000 lux, blue wavelengths) during shift to promote alertness
  • Light avoidance after shift to promote daytime sleep

MEDICATION

  • Sleep-promoting:
  • Melatonin 3 mg (AASM recommended), 30 min before daytime sleep
  • Ramelteon (Rozerem), doxepin (low-dose), trazodone (second-line), nonbenzo hypnotics (zolpidem, eszopiclone, suvorexant)β€”short-term only
  • Wakefulness-promoting:
  • Modafinil 200 mg or armodafinil 150 mg 1h before shift (FDA approved for SWD)
  • Prophylactic caffeine (first half of shift only)
  • Note:
  • Long-term use of hypnotics not recommended; risk of dependence and residual sedation

FIRST LINE

  • Melatonin 3 mg before daytime sleep

SECOND LINE

  • Modafinil/armodafinil before shift, hypnotics before daytime sleep, short-term low-dose antidepressants if needed

REFERRAL

  • Sleep specialist for suspected primary sleep disorders, hypnotic/stimulant dependence, or persistent symptoms

ADDITIONAL THERAPIES

  • Cognitive-behavioral therapy for insomnia (CBT-I)
  • Fatigue risk management programs

ONGOING CARE

  • Patient education on sleep hygiene, environment optimization, risk of accidents with sleep loss
  • Encourage use of sleep diary
  • Symptoms resolve if shift work is eliminated (not always feasible)

ICD-10

  • G47.26: Circadian rhythm sleep disorder, shift work type

CLINICAL PEARLS

  • SWD β†’ increased risk of metabolic and mood disorders
  • First diagnostic step: thorough sleep/work history and 2-week sleep diary
  • Shift workers are at highest accident risk during night/early morning shifts